Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)-insights of people affected by cancer and healthcare professionals: a qualitative study protocol

Efficacy of a Patient Education Session for Cancer Patients Receiving Immunotherapy

OBJECTIVES

Our research questions include: What are gaps in cancer patients' knowledge about immunotherapy? What is the efficacy of an education session in improving cancer patients' knowledge about immunotherapy and reducing inappropriate emergency department (ED) visits?

DATA SOURCES

From July 2020 to September 2021, we invited cancer patients receiving immunotherapy to participate in a one-on-one patient education session and pre-test/post-test surveys. The patient education session included an oral presentation following National Comprehensive Cancer Network guidelines, video on immunotherapy mechanisms of action, and review of written materials and alert cards. The surveys assessed patient knowledge of immunotherapies' mechanisms of action, adverse effects and their management, and health literacy. Survey data were paired with data abstracted from the electronic health record on patient ED utilization and demographic characteristics.

CONCLUSION

Before the education session, knowledge gaps about immunotherapy included understanding the medical term "itis," side effects of immunotherapy, and treatment for side effects of immunotherapy. Overall, the education session significantly improved cancer patients' knowledge about immunotherapy. The education session addressed knowledge gaps by significantly increasing patients' knowledge of immunotherapy mechanisms of action, recognition of side effects, and ability to define the medical term "itis". Because our sample had low inappropriate ED utilization, we could not assess the impact of the education session on inappropriate ED utilization.

IMPLICATIONS FOR NURSING PRACTICE

A multicomponent strategy for patient education was effective in improving overall knowledge uptake, especially among patients who initially had the least knowledge. Future studies should continue to explore whether patient education decreases inappropriate ED utilization.

Between hope and reality: How oncology physicians and information providers of a cancer information service manage patients' expectations for and experiences with immunotherapies

OBJECTIVES

Immune checkpoint inhibitors have established themselves as a further therapeutic pillar in the treatment of various types of cancer. This can create challenges and possible misunderstandings for patients. The aim of this study was to assess the experiences of physicians and information providers in their interactions with patients about immunotherapy.

METHODS

The study design was exploratory with qualitative research methodology. We performed focus groups with 8 oncology physicians and 9 information providers of a cancer information service.

RESULTS

In the coding process, five focal points could be identified: (1) image of immunotherapy, (2) presentation of immunotherapy in the media, (3) hope, (4) creation of an information base, and (5) lessons learned and future directions. Physicians and information providers report that immunotherapy has a very positive image among patients. This seems to be due to the presentation of immunotherapy in the media and the positive associations of people with terms such as the immune system and the body's own defense.

CONCLUSIONS

In contrast to chemotherapy, patients are at risk of underestimating the early symptoms of serious side effects of immunotherapy. From the point of view of physicians, the exaggerated expectations of patients regarding the possibilities of immunotherapy are often not met. The challenge for practitioners is to consider patients' expectations to provide balanced information and recommendations.

PRACTICAL IMPLICATIONS

Communication skills training and up-to-date information tools should improve physician-patient communication.